Suivac APP-emulsie voor injectie voor varken
Suivac APP-emulsie voor injectie voor varken
Authorised
- Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
- Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
Product identification
Medicine name:
Suivac APP-emulsie voor injectie voor varken
Active substance:
- Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
- Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated1.00/enzyme-linked immunosorbent assay unit2.00millilitre(s)
-
Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated1.00/enzyme-linked immunosorbent assay unit2.00millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
All relevant tissuesno withdrawal periodzero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chemvet Pharma ApS
Marketing authorisation date:
Manufacturing sites for batch release:
- Dyntec spol. s r.o.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 124394
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 17/09/2024